相关实验视频
Updated: Sep 18, 2025

09:36
Changes in Mammary Gland Morphology and Breast Cancer Risk in Rats
Published on: October 16, 2010
29.8K
系统性皮质糖类和乳腺癌的风险在一个大型的全国性病例控制研究
Manon Cairat1,2, Morten Olesen2, Elea Olivier1
1Paris-Saclay University, UVSQ, Inserm, Gustave Roussy, Exposome and Heredity Team, CESP, F-94805, Villejuif, France.
Breast cancer research : BCR
|June 23, 2025
概括
长期使用葡萄糖皮质醇与乳腺癌风险增加无关. 这项大型研究没有发现任何证据表明葡萄糖皮质醇使用与更高的乳腺癌发病率有关.
科学领域:
- 内分泌学 在内分泌学.
- 在瘤学瘤学.
- 药学流行病学 药学流行病学
背景情况:
- 关于葡萄糖皮质醇使用与乳腺癌风险之间的联系的证据有限.
- 人们担心,长期使用葡萄糖皮质激素治疗可能会增加乳腺癌发病率.
研究的目的:
- 调查系统性葡萄糖皮质体使用与乳腺癌风险之间的关联.
- 通过乳腺癌亚型,阶段和激素受体状态来分析风险.
主要方法:
- 使用丹麦医疗保健登记册 (2001-2018) 进行全国性病例控制研究.
- 67,829例侵袭性乳腺癌病例与10个对照组相匹配.
- 条件后勤回归计算了葡萄糖皮质激素暴露的几率比率 (ORs).
主要成果:
- 从来使用过葡萄糖皮质醇与乳腺癌风险之间没有联系 (OR=1.00).
- 长期使用 (≥1000定义的每日剂量) 观察到的不良关联 (OR=0.87).
- 建议使用剂量与反应的关系,在较高的累积剂量下,风险较低.
结论:
- 这项研究没有发现证据支持葡萄糖皮质醇使用与乳腺癌风险之间的积极关联.
- 长期使用葡萄糖皮质体可能与乳腺癌风险相反相关.
相关概念视频
Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
210
Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2...
210
Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids
399
Inhaled corticosteroids (ICS) are anti-inflammatory drugs used primarily in treating persistent asthma and providing long-term maintenance. They target the bronchial mucosa, the lining of the airways, to control inflammation, a critical factor in asthma progression and exacerbation.
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
399
Oral Hypoglycemic Agents: Biguanides and Glitazones
310
Biguanides, particularly metformin (Glucophage), are insulin sensitizers that enhance glucose uptake, thereby reducing insulin resistance. Unlike sulfonylureas, metformin doesn't prompt insulin secretion, which helps to curb hypoglycemia risk. Metformin is beneficial in treating conditions like polycystic ovary syndrome due to its insulin-resistance reduction capability. The drug's primary action involves curtailing hepatic gluconeogenesis, a significant contributor to high blood...
310
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
184
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
184
Hypoglycemia and Glucagon
351
Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
351
Cancer Survival Analysis
458
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
458

